Partner Content Partner Content SMi’s Injectable Drug Delivery Releases an Exclusive Intervi... Injectable Drug Delivery 2018
Partner Content Partner Content SMi's Launch, Injectable Drug Delivery 2018 Hosts 2 Interact... Injectable Drug Delivery
Partner Content Partner Content Sanofi Joins the Speaker Line-up for SMi's Launch, Injectabl... SMi's Launch, Injectable Drug Delivery 2018
Events Partner Content From the Pre-filled Syringes Portfolio, SMi Presents: Inject... Injectable Drug Delivery
Partner Content Partner Content Discover Novel Based Vial Based Technology, Presented by Roc... Injectable Drug Delivery
News BioMarin ends year with $4.8bn play for Amicus BioMarin takes a leap towards its $4bn revenue target with a $4.8bn deal to acquire Amicus, which has two rare disease therapies on the market.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
